Latest articles on medicine and pharmacy:
On May 7, 2008 the U.S. Public Health Service issued an updated version of guideline for clinical practice identifying new effective counseling methods and clinical treatments for tobacco dependence. It also urged doctors to follow the new guideline when treating tobacco dependence.
The new guideline called Treating Tobacco Use and Dependence: 2008 Update was created by the leading national experts in tobacco cessation and sponsored by a consortium of non-profit organizations. Having reviewed thousands of research articles, the authors continue to recommend NRT (nicotine replacement) products such as nicotine gum, nicotine nasal spray, nicotine patch, etc. used to help smokers break their tobacco dependence.
Medical trials on mice show that new anti-obesity drugs may suppress neural development in children. The results of a recent research conducted by Massachusetts Institute of Technology were published in journal Neuron.
The researchers conclude that drugs such as Acomplia (Rimonabant) that function by blocking cannabinoid receptors of the brain responsible for appetite also affect adaptive rewiring of the brain. Mark Bear, director of the Picower Institute and Professor of Neuroscience, suggests that such drugs should be given to children with caution.
Depression is treatable by psychiatric medications as well as by psychotherapy. Under the influence of medications, depression often decreases; those so-afflicted become more functional with greater ease.
Unfortunately, depression often returns if the medication is withdrawn. Additionally, there are very frequently unpleasant side-effects to the medication. Last, medication teaches nothing, although people do learn more easily while taking it.
It has fallen to psychotherapy to teach the depressed how to function and cope with their depression. Psychotherapy forms an almost essential part in the treatment recipe of depression and complements the use of medication. What is often learned with psychotherapy is often hard won, and over a long period.
The information at this web site is presented for historic, educational, and informational purposes only. Nothing herein is intended to be instruction for clinical use. This information does not necessarily represent the current state of the art of applying the Flexyx Neurotherapy System (FNS), which can only come from extended training programs.
Any representation that other systems linking EEG and stimulation are the same as FNS is a misrepresentation. There are no other "Len Ochs-" or "Flexyx-type" protocols. Nor is any other system linking EEG and stimulation authorized or licensed by Flexyx or Len Ochs, individually.